Exodus Point Capital Management, LP Immunic, Inc. Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$11.76 - $16.85 $179,751 - $257,552	-15,285 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$14.21 - $25.3 $217,199 - $386,710	15,285 New	15,285 $244,000
Q3 2020 Nov 16, 2020	SELL	$11.74 - $22.0 $124,854 - $233,970	-10,635 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.67 - $15.86 $60,300 - $168,671	10,635 New	10,635 $129,000

56.1M

4.7K

311K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $50.4M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.